The healthcare sector's standout performer is Eli Lilly, primarily due to the ongoing boom in GLP-1 weight-loss drugs. In early 2026, the company reported triple-digit revenue growth for its blockbuster treatments, Mounjaro and Zepbound. Analysts project 26% revenue growth for the full year, supported by an aging population and a "near-guaranteed" growth trajectory for essential medical services.
As the primary manufacturer for tech giants like Nvidia and Apple, TSM is a foundational play for the AI infrastructure boom. After crushing fourth-quarter results with 26% revenue growth, management signaled an aggressive $52–$56 billion capital expenditure plan for 2026 to meet "huge and lasting" chip demand. Analysts forecast significant upside for the year as AI spending continues to accelerate. top ten shares to buy today
AMD has solidified its position as the primary challenger to Nvidia in the AI and data center arenas. While its stock can be volatile, long-term investors are increasingly bullish on its lineup of CPUs and AI accelerators. Analysts recommend it for its potential to capture a larger share of the $3 trillion data center market over the next five years. The healthcare sector's standout performer is Eli Lilly,
Within the financial sector, Wells Fargo is gaining attention following the lifting of a punitive asset cap by the Federal Reserve in 2025. This policy change has unlocked new growth opportunities, allowing the bank to expand its lending significantly. Analysts from CFRA currently see an implied upside of roughly 44% for the stock as it moves toward higher returns on equity. As the primary manufacturer for tech giants like